These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11747904)

  • 61. Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus.
    Cannizzaro C; D'Amico M; Preziosi P; Martire M
    Neurochem Int; 2006 Feb; 48(3):159-65. PubMed ID: 16325966
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
    Ishioka N; Bukoski RD
    J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea-pig distal colon in vitro.
    Kojima S; Sugiura T; Waku K; Kamikawa Y
    Eur J Pharmacol; 2002 May; 444(3):203-7. PubMed ID: 12063081
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Concentration-dependent dual effect of anandamide on sensory neuropeptide release from isolated rat tracheae.
    Németh J; Helyes Z; Thán M; Jakab B; Pintér E; Szolcsányi J
    Neurosci Lett; 2003 Jan; 336(2):89-92. PubMed ID: 12499047
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeting the cannabinoid system for pain relief?
    Chiou LC; Hu SS; Ho YC
    Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Possible mechanisms of cannabinoid-induced antinociception in the spinal cord.
    Morisset V; Ahluwalia J; Nagy I; Urban L
    Eur J Pharmacol; 2001 Oct; 429(1-3):93-100. PubMed ID: 11698030
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons.
    Mahmud A; Santha P; Paule CC; Nagy I
    Neuroscience; 2009 Sep; 162(4):1202-11. PubMed ID: 19463903
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons.
    Roberts LA; Christie MJ; Connor M
    Br J Pharmacol; 2002 Oct; 137(4):421-8. PubMed ID: 12359623
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide.
    Geraghty DP; Mazzone SB
    Br J Pharmacol; 2002 Nov; 137(6):919-27. PubMed ID: 12411424
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
    De Petrocellis L; Melck D; Palmisano A; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8375-80. PubMed ID: 9653194
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges.
    Schmid HH; Schmid PC; Berdyshev EV
    Chem Phys Lipids; 2002 Dec; 121(1-2):111-34. PubMed ID: 12505695
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves.
    Kurihara J; Nishigaki M; Suzuki S; Okubo Y; Takata Y; Nakane S; Sugiura T; Waku K; Kato H
    Jpn J Pharmacol; 2001 Sep; 87(1):93-6. PubMed ID: 11676206
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anandamide: some like it hot.
    Di Marzo V; Bisogno T; De Petrocellis L
    Trends Pharmacol Sci; 2001 Jul; 22(7):346-9. PubMed ID: 11431028
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors.
    Mang CF; Erbelding D; Kilbinger H
    Br J Pharmacol; 2001 Sep; 134(1):161-7. PubMed ID: 11522608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors.
    Williams CM; Kirkham TC
    Psychopharmacology (Berl); 1999 Apr; 143(3):315-7. PubMed ID: 10353436
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anandamide: an endogenous activator of the vanilloid receptor.
    Smart D; Jerman JC
    Trends Pharmacol Sci; 2000 Apr; 21(4):134. PubMed ID: 10740287
    [No Abstract]   [Full Text] [Related]  

  • 78. Cannabinoid receptor mediated inhibition of excitatory synaptic transmission in the rat hippocampal slice is developmentally regulated.
    Al-Hayani A; Davies SN
    Br J Pharmacol; 2000 Oct; 131(4):663-5. PubMed ID: 11030713
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of cannabinoids on synaptic transmission in the rat hippocampal slice is temperature-dependent.
    Al-Hayani A; Davies SN
    Eur J Pharmacol; 2002 May; 442(1-2):47-54. PubMed ID: 12020681
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The gastrointestinal pharmacology of cannabinoids.
    Izzo AA; Mascolo N; Capasso F
    Curr Opin Pharmacol; 2001 Dec; 1(6):597-603. PubMed ID: 11757815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.